Results 231 to 240 of about 11,553 (254)
Some of the next articles are maybe not open access.
ASAIO Journal, 2022
The Impella CP (Abiomed Inc., Danvers, MA) is widely used in cardiac catheterization laboratories for patients presenting with cardiogenic shock, but it is also known to cause significant hemolysis. The risk of hemolysis can be reduced by properly positioning the device, ensuring an adequate volume status, and using full anticoagulation strategies ...
Ismael Salas de Armas +11 more
openaire +2 more sources
The Impella CP (Abiomed Inc., Danvers, MA) is widely used in cardiac catheterization laboratories for patients presenting with cardiogenic shock, but it is also known to cause significant hemolysis. The risk of hemolysis can be reduced by properly positioning the device, ensuring an adequate volume status, and using full anticoagulation strategies ...
Ismael Salas de Armas +11 more
openaire +2 more sources
Impella Management for the Cardiac Intensivist
ASAIO Journal, 2022The Impella mechanical circulatory support (MCS) system is a catheter-based continuous flow cardiac assist device that is widely used in the treatment of cardiogenic shock in medical and surgical cardiac intensive care units. As with all forms of MCS, device-related complications remain a major concern, the incidence of which can be mitigated by ...
Alexander I. Papolos +4 more
openaire +2 more sources
Implanting Impella 5.5 under Local Anesthesia
The Thoracic and Cardiovascular Surgeon, 2023Abstract Background Surgically implanted Impella 5.5. delivers full cardiac support and left ventricular unloading for patients with heart failure. So far, the Impella device is implanted under general anesthesia (GA). Material and Methods A total of n = 3 critically ill patients presented with acute heart failure in need of cardiac
Kaveh Eghbalzadeh +2 more
openaire +2 more sources
Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention
The American Journal of CardiologyThe benefit of mechanical circulatory support with Impella (Abiomed, Inc., Danvers, Massachusetts) for high-risk percutaneous coronary intervention (HR-PCI) is uncertain. PROTECT III registry data showed improved outcomes with Impella compared with historical data (PROTECT II) but lack a direct comparison with the HR-PCI cohort without Impella support.
Pavan Reddy +9 more
openaire +3 more sources
2019
The Abiomed Impella platform consists of four percutaneous trans-valvular micro axial-flow acute mechanical circulatory support (AMCS) devices that provide either left or right hemodynamic support for indications of high-risk coronary intervention or cardiogenic shock.
Shiva K. Annamalai +5 more
openaire +1 more source
The Abiomed Impella platform consists of four percutaneous trans-valvular micro axial-flow acute mechanical circulatory support (AMCS) devices that provide either left or right hemodynamic support for indications of high-risk coronary intervention or cardiogenic shock.
Shiva K. Annamalai +5 more
openaire +1 more source
Giornale Italiano di Cardiologia
The Impella 5.5® (Abiomed Inc., Danvers, MA, USA) is a temporary mechanical circulatory support device utilized for the management of cardiogenic shock. In this review, we outline the device's key features, paying particular attention to its indications and contraindications, the surgical technique for implantation, and potential complications ...
Buttiglione, Gianpiero +12 more
openaire +3 more sources
The Impella 5.5® (Abiomed Inc., Danvers, MA, USA) is a temporary mechanical circulatory support device utilized for the management of cardiogenic shock. In this review, we outline the device's key features, paying particular attention to its indications and contraindications, the surgical technique for implantation, and potential complications ...
Buttiglione, Gianpiero +12 more
openaire +3 more sources
A and V Pub International Journal of Nursing and Medical Research
The Impella small catheter like 6 inch long device which works on principle of submersible water pump. It is inserted in to heart without any surgical procedure it provides 2.5- 5.5 litters/min blood flow. Impella device is available in various types according to their location, size and flow rate.
Mayavati Tupere, Lakshman Mane
openaire +1 more source
The Impella small catheter like 6 inch long device which works on principle of submersible water pump. It is inserted in to heart without any surgical procedure it provides 2.5- 5.5 litters/min blood flow. Impella device is available in various types according to their location, size and flow rate.
Mayavati Tupere, Lakshman Mane
openaire +1 more source
Impella removal with access site salvage
Catheterization and Cardiovascular Interventions, 2018AbstractRemoval of the percutaneous Impella CP assist device while maintaining femoral artery access site is not always possible. This case highlights a technique of Impella removal with access site salvage.
Neil Yager, Sergio Waxman
openaire +2 more sources
Standardization of Impella®-assisted patient management
Minerva Cardioangiologica, 2018The presence of high-risk features on candidates to percutaneous revascularization is increasingly leading to Impella®-assisted procedures (IAPs). While IAPs are safe and effective procedures, they still require managing a degree of complexity. Clinicians often rely on their ability to recall every step of operative procedures.
Tommaso, Sanna +3 more
openaire +2 more sources
Die chirurgisch implantierte Impella
2020Die chirurgisch implantierte Impella hat in den letzten Jahren erheblich an Bedeutung gewonnen und wurde in zunehmendem Mase in Deutschland und weltweit implantiert. Initial entwickelt, femoral oder direkt aortal implantiert zu werden, werden die chirurgisch implantierten Impella-Gerate mittlerweile fast ausschlieslich axillar implantiert.
openaire +1 more source